Cyclica announced that it has entered into a licensing agreement with Merck KGaA, Darmstadt, Germany for the use of Ligand Express®, a cloud-based in silico proteome screening platform.
Advanced Code injection
Cyclica announced that it has entered into a licensing agreement with Merck KGaA, Darmstadt, Germany for the use of Ligand Express®, a cloud-based in silico proteome screening platform.